Chinese research team achieves new breakthroughs in autoimmune hepatitis treatment

2026-03-28 00:47:40

A Chinese research team recently made significant progress in the treatment of autoimmune hepatitis. The joint research team from Qilu Hospital of Shandong University and the School of Pharmacy of Shandong University proposed a new method based on in vivo cell reprogramming, providing new insights for the treatment of autoimmune diseases. The relevant research findings have been published in the international academic journal “Cell Stem Cell.” (Xinhua News Agency)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.